Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 308,304 | 280,499 | 179,338 | 141,666 | 144,121 |
| Marketable Securities | N/A | N/A | N/A | N/A | 1,966 |
| Receivables | 120,479 | 60,191 | 66,238 | 96,043 | 83,659 |
| Inventories | 60,887 | 65,674 | 14,643 | 15,161 | 14,661 |
| Income taxes - deferred | N/A | 1,710 | N/A | 1,264 | 1,735 |
| Other current assets | 29,282 | 0 | 0 | 0 | 0 |
| TOTAL | $537,410 | $432,175 | $273,115 | $263,347 | $254,418 |
| Non-Current Assets | |||||
| PPE Net | 327,808 | 313,979 | 264,240 | 241,764 | 208,973 |
| Intangibles | 81,759 | 110,929 | 44,102 | 5,502 | 5,502 |
| Other Non-Current Assets | 90,507 | 81,608 | 45,173 | 53,617 | 77,971 |
| TOTAL | $500,074 | $506,516 | $353,515 | $300,883 | $292,446 |
| Total Assets | $1,037,484 | $938,691 | $626,630 | $564,230 | $546,864 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 4,470 | 5,360 |
| Accounts payable and accrued liabilities | 37,970 | 40,930 | 27,521 | 31,297 | 40,530 |
| Accrued Expenses | 38,205 | 37,928 | 25,867 | 24,214 | 22,054 |
| Other current liabilities | 2,109 | 8,733 | 1,341 | N/A | 1,748 |
| TOTAL | $99,611 | $92,936 | $56,651 | $61,907 | $71,054 |
| Non-Current Liabilities | |||||
| Long Term Debt | 246,892 | 251,000 | 62,000 | 58,304 | 54,094 |
| Deferred Revenues | 3,979 | 5,345 | 1,834 | 1,811 | 1,362 |
| Other Non-Current Liabilities | 27,538 | 35,841 | 18,271 | 7,272 | 11,895 |
| TOTAL | $277,856 | $292,554 | $80,814 | $60,195 | $59,083 |
| Total Liabilities | $377,467 | $385,490 | $137,465 | $122,102 | $130,137 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,474 | 37,918 | 36,772 | 35,926 | 36,015 |
| Common Shares | 40 | 38 | 37 | 36 | 36 |
| Retained earnings | 351,139 | 288,269 | 251,528 | 220,393 | 196,869 |
| Other shareholders' equity | -3,133 | -3,328 | -4,037 | -3,265 | -832 |
| TOTAL | $660,017 | $553,201 | $489,165 | $442,128 | $416,727 |
| Total Liabilities And Equity | $1,037,484 | $938,691 | $626,630 | $564,230 | $546,864 |